{
    "title": "A bill to improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Safe Tissue Act''.\n\nSEC. 2. DEFINITIONS.\n\n    In this Act:\n            (1) Establishment.--The term ``establishment'' has the \n        meaning given such term in section 1271.3 of title 21, Code of \n        Federal Regulations (or any successor regulation).\n            (2) Human cells, tissues, or cellular or tissue-based \n        products.--The term ``human cells, tissues, or cellular or \n        tissue-based products'' has the meaning given such term in \n        section 1271.3 of title 21, Code of Federal Regulations (or any \n        successor regulation).\n            (3) Secretary.--The term ``Secretary'' means the Secretary \n        of Health and Human Services.\n\nSEC. 3. INSPECTIONS AND AUDITS BY THE FOOD AND DRUG ADMINISTRATION.\n\n    (a) Inspections of Tissue Banks.--\n            (1) In general.--Notwithstanding section 1271.400(b) of \n        title 21, Code of Federal Regulations, the Food and Drug \n        Administration shall inspect each establishment regulated by \n        such section not less than once every 2 years.\n            (2) User fees.--The Secretary may establish a user fee \n        program applicable to each establishment under part 1271 of \n        title 21, Code of Federal Regulations, to fund the inspections \n        required by paragraph (1).\n    (b) Audits of Tissue Banks.--The Food and Drug Administration shall \nconduct periodic audits of all documentation submitted by each \nestablishment under part 1271 of title 21, Code of Federal Regulations, \nto determine compliance with all applicable requirements, including \nthose requirements related to ensuring--\n            (1) that human cells, tissues, or cellular or tissue-based \n        products are obtained by the establishment legally;\n            (2) that donor eligibility and donor medical history \n        interviews are based on accurate information that was not \n        provided or obtained in a fraudulent manner; and\n            (3) current good tissue practice.\n\nSEC. 4. DEVELOPMENT OF MODEL CONSENT FORM.\n\n    (a) In General.--The Secretary shall publish in the Federal \nRegister a model form containing minimum requirements for \nestablishments to use in obtaining consent from a potential donor, or \nthe legally authorized representative of a potential donor, of human \ncells, tissues, or cellular or tissue-based products.\n    (b) Content.--The model form under subsection (a) shall include--\n            (1) requirements for obtaining consent from a potential \n        donor, or the legally authorized representative of a potential \n        donor, regarding--\n                    (A) the type of human cells, tissues, or cellular \n                or tissue-based product to be donated;\n                    (B) the purpose for which such human cells, \n                tissues, or cellular or tissue-based products shall be \n                used, such as transplantation for medical purposes, \n                transplantation for cosmetic purposes, therapy, \n                research, or medical education; and\n                    (C) other matters as determined appropriate by the \n                Secretary;\n            (2) a requirement that an establishment provide assurance \n        to the Secretary and a potential donor, or the legally \n        authorized representative of a potential donor, that such an \n        establishment will only obtain consent directly from such donor \n        or representative; and\n            (3) a requirement that an establishment--\n                    (A) provide, upon request, to the potential donor, \n                or the legally authorized representative of a potential \n                donor, a description of the recovery process for human \n                cells, tissues, or cellular or tissue-based products;\n                    (B) inform such donor or representative of the \n                right to receive such a description; and\n                    (C) inform such donor or representative of whether \n                the establishment is accredited under the regulations \n                promulgated by the Secretary pursuant to section 5.\n    (c) Use of Model Form.--The Secretary shall promulgate regulations \nrequiring that establishments provide and obtain no less information \nthan that specified in the model form under subsection (a) prior to \naccepting a donation of human cells, tissues, or cellular or tissue-\nbased products.\n    (d) Enforcement.--\n            (1) Failure to comply with requirements.--An establishment, \n        or an individual employed by an establishment, that fails to \n        comply with the requirements of the model form under subsection \n        (a) shall be subject to a civil penalty of not more than \n        $5,000.\n            (2) Use of fraudulent information.--An establishment, or an \n        individual employed by an establishment, that knowingly uses \n        fraudulent information for, or fraudulent means of, obtaining \n        the consent described under the model form under subsection (a) \n        shall be--\n                    (A) fined not more than $10,000, or imprisoned for \n                not more than 6 months, or both, for the first such \n                violation; and\n                    (B) fined not more than $250,000, or imprisoned for \n                not more than 10 years, or both, for the second and any \n                subsequent such violation.\n    (e) Preemption.--The model form regulations promulgated under \nsubsection (c) shall supercede any provisions of the law with respect \nto obtaining consent from a potential donor, or legally authorized \nrepresentative of a potential donor, of human cells, tissues, or \ncellular or tissue-based products, of the State in which an \nestablishment operates to the extent such law is less stringent than \nthe requirements imposed under such subsection.\n\nSEC. 5. ACCREDITATION OF ESTABLISHMENTS AND PERSONNEL.\n\n    (a) In General.--The Secretary shall promulgate regulations to \naccredit--\n            (1) establishments; and\n            (2) the personnel of establishments who participate in the \n        recovery, processing, storage, labeling, packaging, or \n        distribution of human cells, tissues, or cellular or tissue-\n        based products.\n    (b) Authority of Secretary.--In promulgating the regulations under \nsubsection (a), the Secretary shall--\n            (1) establish an accreditation process modeled after the \n        Joint Commission on Accreditation of Healthcare Organizations; \n        or\n            (2) adopt an accreditation process established by a private \n        entity that is in effect as of the date of enactment of this \n        Act.\n\nSEC. 6. DETERMINATION OF REASONABLE PAYMENTS.\n\n    The Secretary shall promulgate regulations defining ``reasonable \npayments'' for the purposes of section 301(c)(2) of the National Organ \nTransplant Act (42 U.S.C. 274e(c)(2)), as such section relates to human \ntissue and tissue-based products regulated under part 1271 of title 21, \nUnited States Code."
}